Flyttr
≈ 3 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Flyttr (previously Oxitec) is a multinational biotechnology company that develops genetically modified insects in order to improve public health and food security through insect control. The insects act as biological insecticides. The company claims that this technology is more effective and more environmentally friendly than chemical insecticides. The main principle behind Flyttr's mosquito control technology is release of genetically engineered male insects whose female offspring dies before reaching maturity. Flyttr has developed tools to control the mosquito species Anopheles stephensi, Anopheles albimanus, and Aedes aegypti. Additionally they've developed tools against the pink bollworm, and the diamondback moth as well as other insects and arachnids.
Flyttr (previously Oxitec) is a multinational biotechnology company that develops genetically modified insects in order to improve public health and food security through insect control. The insects act as biological insecticides. The company claims that this technology is more effective and more environmentally friendly than chemical insecticides. The main principle behind Flyttr's mosquito control technology is release of genetically engineered male insects whose female offspring dies before reaching maturity. Flyttr has developed tools to control the mosquito species Anopheles stephensi, Anopheles albimanus, and Aedes aegypti. Additionally they've developed tools against the pink bollworm, and the diamondback moth as well as other insects and arachnids.
History
Oxitec was founded in 20021 as Oxford Insect Technologies in the United Kingdom by Luke Alphey and David Kelly, working with Oxford University's Isis Innovation technology transfer company. In August 2015, Oxitec was purchased by U.S.-based Intrexon for $160 million, and by US-based Third Security in early 2020. The company's first engineered insect was the pink bollworm (Pectinophora gossypiella). It was experimentally released in Arizona in 20061. The company then modified Aedes aegypti, a mosquito which spreads dengue fever, yellow fever, and chikungunya, followed by a series of field trials in multiple countries. Grey Frandsen was appointed CEO in 2017. He is an American who led start-up initiatives in the U.S. government and the private and non-profit sectors on matters relating to national and global public health security, biotechnology and crisis response. Frandsen led the company's transition to its 2nd generation technology in 2018. During the 2010s, Oxitec established partnerships with agricultural industry leaders and the Bill & Melinda Gates Foundation. Frandsen was named one of Malaria No More's 10-to-End innovators in 2019.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1378707207 under CC BY-SA 4.0; modifications have been made.
References
- ↩Wikipedia “Flyttr” release date (×2) · confidence 0.95 revision URL